These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30407311)

  • 1. Ursodeoxycholic acid after common bile duct stones removal for prevention of recurrence: A systematic review and meta-analysis of randomized controlled trials.
    Chen X; Yan XR; Zhang LP
    Medicine (Baltimore); 2018 Nov; 97(45):e13086. PubMed ID: 30407311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ursodeoxycholic acid after bile duct stone removal and risk factors for recurrence: a randomized trial.
    Yamamoto R; Tazuma S; Kanno K; Igarashi Y; Inui K; Ohara H; Tsuyuguchi T; Ryozawa S
    J Hepatobiliary Pancreat Sci; 2016 Feb; 23(2):132-6. PubMed ID: 26705893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of combined ursodeoxycholic acid and glucocorticoid on the outcome of Kasai procedure: A systematic review and meta-analysis.
    Qiu JL; Shao MY; Xie WF; Li Y; Yang HD; Niu MM; Xu H
    Medicine (Baltimore); 2018 Aug; 97(35):e12005. PubMed ID: 30170405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of ursodeoxycholic acid as an adjuvant treatment to prevent acute cellular rejection after liver transplantation: a meta-analysis of randomized controlled trials.
    Deng YL; Xiong XZ; Cheng NS
    Hepatobiliary Pancreat Dis Int; 2014 Oct; 13(5):464-73. PubMed ID: 25308356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing the efficacy of endoscopic balloon dilation alone and combined with endoscopic sphincterotomy for common bile duct stone: a systematic review and meta-analysis.
    Hu J; Mu N; He Y
    Ann Palliat Med; 2022 Jan; 11(1):163-172. PubMed ID: 35144408
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acupuncture for enhancing early recovery of bowel function in cancer: Protocol for a systematic review.
    Liu YH; Ye Y; Zheng JB; Wang XQ; Zhang Y; Lin HS
    Medicine (Baltimore); 2017 Apr; 96(17):e6644. PubMed ID: 28445263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-stage laparoscopic common bile duct exploration and cholecystectomy versus two-stage endoscopic stone extraction followed by laparoscopic cholecystectomy for patients with gallbladder stones with common bile duct stones: systematic review and meta-analysis of randomized trials with trial sequential analysis.
    Singh AN; Kilambi R
    Surg Endosc; 2018 Sep; 32(9):3763-3776. PubMed ID: 29603004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent common bile duct stones composed of ursodeoxycholic acid: a report of four cases.
    Akiyama S; Imamura T; Tamura T; Koizumi Y; Koyama R; Takeuchi K; Watanabe G
    Intern Med; 2014; 53(21):2489-92. PubMed ID: 25366008
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repurposing an Old Drug for a New Epidemic: Ursodeoxycholic Acid to Prevent Recurrent Clostridioides difficile Infection.
    Webb BJ; Brunner A; Lewis J; Ford CD; Lopansri BK
    Clin Infect Dis; 2019 Jan; 68(3):498-500. PubMed ID: 30020421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of Ursodeoxycholic Acid in the Prevention of Cholelithiasis After Sleeve Gastrectomy.
    Coupaye M; Calabrese D; Sami O; Siauve N; Ledoux S
    Obes Surg; 2019 Aug; 29(8):2464-2469. PubMed ID: 30945151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term effects of mid-dose ursodeoxycholic acid in primary biliary cirrhosis: a meta-analysis of randomized controlled trials.
    Shi J; Wu C; Lin Y; Chen YX; Zhu L; Xie WF
    Am J Gastroenterol; 2006 Jul; 101(7):1529-38. PubMed ID: 16863557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ursodeoxycholic acid for the prevention of symptomatic gallstone disease after bariatric surgery: study protocol for a randomized controlled trial (UPGRADE trial).
    Boerlage TCC; Haal S; Maurits de Brauw L; Acherman YIZ; Bruin S; van de Laar AWJM; Moes DE; van Wagensveld BA; de Vries CEE; van Veen R; Schouten R; Dijkgraaf MG; Fockens P; Gerdes VEA; Voermans RP
    BMC Gastroenterol; 2017 Dec; 17(1):164. PubMed ID: 29262795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Ursodeoxycholic Acid in the Prevention of Gallstones Formation in Bariatric Patients-a Systematic Review and Meta-Analysis of Randomised Trials.
    Sharma A; Shanti H; Nageswaran H; Best LMJ; Patel AG
    Obes Surg; 2023 Dec; 33(12):4115-4124. PubMed ID: 37872257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Meta-analysis of ursodeoxycholic acid and S-adenosylmethionine for improving the outcomes of intrahepatic cholestasis of pregnancy].
    Zhou F; Gao B; Wang X; Li J
    Zhonghua Gan Zang Bing Za Zhi; 2014 Apr; 22(4):299-304. PubMed ID: 25173231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ursodeoxycholic acid combined with percutaneous transhepatic balloon dilation for management of gallstones after elimination of common bile duct stones.
    Chang HY; Wang CJ; Liu B; Wang YZ; Wang WJ; Wang W; Li D; Li YL
    World J Gastroenterol; 2018 Oct; 24(39):4489-4498. PubMed ID: 30356997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gallstone recurrence after successful dissolution therapy.
    Tudyka J; Wechsler JG; Kratzer W; Maier C; Mason R; Kuhn K; Adler G
    Dig Dis Sci; 1996 Feb; 41(2):235-41. PubMed ID: 8601364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: Relation to disease progression.
    Sinakos E; Marschall HU; Kowdley KV; Befeler A; Keach J; Lindor K
    Hepatology; 2010 Jul; 52(1):197-203. PubMed ID: 20564380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical strategy for recurrent common bile duct stones: a 10-year experience of a single center.
    Xia H; Xin X; Yang T; Liu Y; Liang B; Wang J
    Updates Surg; 2021 Aug; 73(4):1399-1406. PubMed ID: 32970309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological interventions for primary biliary cholangitis: an attempted network meta-analysis.
    Saffioti F; Gurusamy KS; Eusebi LH; Tsochatzis E; Davidson BR; Thorburn D
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011648. PubMed ID: 28350426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ursodeoxycholic acid for primary biliary cirrhosis.
    Gong Y; Huang ZB; Christensen E; Gluud C
    Cochrane Database Syst Rev; 2008 Jul; (3):CD000551. PubMed ID: 18677775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.